US 11926625
HPK1 antagonists and uses thereof
granted A61PA61P31/12A61P35/00
Quick answer
US patent 11926625 (HPK1 antagonists and uses thereof) held by Nimbus Saturn, Inc. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nimbus Saturn, Inc.
- Grant date
- Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P31/12, A61P35/00